Ibex Preclinical Research — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Ibex Preclinical Research is a specialized preclinical CRO that accelerates medical device validation for MedTech companies through expert-led, GLP-compliant studies. Founded in 2018 and AAALAC-accredited, it offers a full-service facility with in-house surgical suites, advanced imaging, and custom model development to generate critical safety and performance data. The company differentiates itself with rapid lead times (2-3 weeks), a surgeon-informed approach to protocol design, and a strong focus on orthopedic, spine, and surgical device sectors, positioning it as a partner for FDA-focused startups and established device manufacturers.

OncologyNeuroscienceCardiovascular

Technology Platform

Integrated AAALAC-accredited, GLP-compliant preclinical research facility featuring in-house surgical suites, advanced real-time imaging (fluoroscopy, ultrasound), and expertise in developing custom large-animal and human cadaver surgical models for medical device testing.

Opportunities

Growth is driven by increasing outsourcing of complex preclinical work by medical device companies, particularly venture-backed startups needing speed and regulatory guidance.

Expansion into validating devices for emerging surgical trends like robotics and digital surgery presents further opportunity.

Risk Factors

Revenue is tied to the R&D spending cycles of the MedTech industry, creating vulnerability to economic downturns.

Maintaining AAALAC accreditation and GLP compliance is critical; any lapse would severely damage reputation and business viability.

Intense competition from larger CROs could pressure pricing and margins.

Competitive Landscape

Ibex competes in the preclinical CRO market, facing competition from large, full-service CROs (e.g., Charles River, Labcorp) and other specialized surgical/device CROs. It differentiates through a focused expertise in complex orthopedic/surgical models, rapid turnaround times, and an integrated facility, positioning itself as a premium boutique partner for MedTech innovators.

More companies in Digital Health & Biotech SaaS →More companies in United States →